Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

7.99
Delayed Data
As of Sep 26
 -0.07 / -0.87%
Today’s Change
6.68
Today|||52-Week Range
24.50
-51.69%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close8.06
Today’s open7.96
Day’s range7.91 - 8.24
Volume175,718
Average volume (3 months)295,027
Market cap$200.0M
Dividend yield--
Data as of 09/26/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)-0.97%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
CYADCelyad SA+0.60+2.84%
CBMGCellular Biomedicine...-0.30-2.04%
PIPPharmAthene Inc-0.01-0.35%
ASTAsterias Biotherapeu...-0.11-2.37%
Data as of 09/26/2016

Financials

Next reporting dateNovember 28, 2016
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Search for Jobs